Search research articles
Contact Us
Filters
Showing results (71-80 of 113) with videos related to
Page
of 12
Sort By:
Cell Reports. Medicine
|
June 7, 2021
Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinoma
Hui-Wen Lue, Daniel S Derrick, Soumya Rao, et al.
Clinical Genitourinary Cancer
|
December 3, 2014
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer
Kevin D Courtney, Judith B Manola, Aymen A Elfiky, et al.
Cancer
|
February 15, 2024
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer
Sandip P Patel, Elizabeth Guadarrama, Young Kwang Chae, et al.
Magnetic Resonance Imaging
|
August 18, 2012
Promise and pitfalls of quantitative imaging in oncology clinical trials
Brenda F Kurland, Elizabeth R Gerstner, James M Mountz, et al.
Journal for Immunotherapy of Cancer
|
September 29, 2024
Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the desmoid tumors
Young Kwang Chae, Megan Othus, Sandip Patel, et al.
Research Square
|
January 7, 2025
Concurrent preoperative eribulin and radiation for resectable retroperitoneal liposarcoma: a phase 1B study
Lara Davis, Limin Zhu, Skye C Mayo, et al.
European Urology
|
May 23, 2018
Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis
Maxine Sun, Lorenzo Marconi, Tim Eisen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2024
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers
Young Kwang Chae, Lucy Corthell, Sandip Pravin Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2019
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
Lara E Davis, Vanessa Bolejack, Christopher W Ryan, et al.
Cancer Medicine
|
August 11, 2022
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results
Steven Attia, Vanessa Bolejack, Kristen N Ganjoo, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 113) with videos related to
Sort By:
Page
of 12
Cell Reports. Medicine
|
June 7, 2021
Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinoma
Hui-Wen Lue, Daniel S Derrick, Soumya Rao, et al.
Clinical Genitourinary Cancer
|
December 3, 2014
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer
Kevin D Courtney, Judith B Manola, Aymen A Elfiky, et al.
Cancer
|
February 15, 2024
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer
Sandip P Patel, Elizabeth Guadarrama, Young Kwang Chae, et al.
Magnetic Resonance Imaging
|
August 18, 2012
Promise and pitfalls of quantitative imaging in oncology clinical trials
Brenda F Kurland, Elizabeth R Gerstner, James M Mountz, et al.
Journal for Immunotherapy of Cancer
|
September 29, 2024
Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the desmoid tumors
Young Kwang Chae, Megan Othus, Sandip Patel, et al.
Research Square
|
January 7, 2025
Concurrent preoperative eribulin and radiation for resectable retroperitoneal liposarcoma: a phase 1B study
Lara Davis, Limin Zhu, Skye C Mayo, et al.
European Urology
|
May 23, 2018
Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis
Maxine Sun, Lorenzo Marconi, Tim Eisen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2024
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers
Young Kwang Chae, Lucy Corthell, Sandip Pravin Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2019
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
Lara E Davis, Vanessa Bolejack, Christopher W Ryan, et al.
Cancer Medicine
|
August 11, 2022
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results
Steven Attia, Vanessa Bolejack, Kristen N Ganjoo, et al.
Page
of 12